ArticleMalaria journal2026
Community perspective on feasibility of malaria mass drug administration: a qualitative evidence from the Eastern Region of Ghana.
Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria remains the leading cause of morbidity and mortality in Ghana, particularly in rural high-burden communities. Mass drug administration (MDA) has re-emerged as a complementary strategy to reduce transmission, yet community acceptability and implementation challenges remain underexplored.
methodsWe conducted a cross-sectional study in the Pokrom subdistrict following pilot mass drug administration (MDA) interventions. Data were collected through eleven focus group discussions (FGDs), nine with community members and two with healthcare providers, comprising 97 participants, as well as eight in-depth interviews (IDIs) with assemblymen, healthcare providers and personnel of malaria elimination programme. Thes were complemented by field notes. Participants were purposively selected from individuals who had participated in the MDA interventions and provided informed consent. This study explored community perceptions of malaria burden, perceived MDA effectiveness, reported adverse events, health-seeking behaviour, financial implications and acceptability. Transcripts were analysed thematically using a hybrid inductive-deductive approach informed by reflexive thematic analysis.
resultsMalaria was widely identified as the most pressing health concern in the subdistrict prior to the MDA intervention, with frequent hospitalisation and substantial household expenditure on treatment reported. Following the MDA interventions, notable reductions in malaria episodes were described, with some households transitioning from frequent infections to rare or no illness. These perceived improvements were accompanied by decreased healthcare-related costs, indicating important financial and economic benefits. Though adverse events, including dizziness, abdominal pain, and weakness, were reported, they were generally perceived as mild and transient. Initial challenges included inadequate community sensitization and negative messaging from some health workers, which temporarily affected uptake. Despite these concerns, willingness to participate in future MDA rounds remained high among community members, with recommendations emphasizing continued sensitization, strengthened drug delivery systems, and enhanced monitoring of side effects.
conclusionsThe MDA interventions were widely perceived as beneficial in reducing malaria burden and associated household healthcare costs in rural Ghana. Consistent with the Theoretical Framework of Acceptability, perceived effectiveness and economic benefits outweighed the burden of transient adverse events, contributing to perceived high community acceptability. Strengthening communication, pharmacovigilance, and community engagement could be critical for sustaining uptake and supporting the potential scale-up of MDA in high-burden malaria settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.